此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

分娩期间使用昏暗灯光对疼痛、焦虑及产程进展的影响 (DIM-LIGHT)

2026年9月26日 更新者:Pınar Erdoğan

《分娩期间弱光(≤80勒克斯)照射对疼痛、焦虑及产程进展的影响:一项单中心随机对照试验》

The environment of the labor room may influence how women experience childbirth. Light levels, in particular, may affect comfort, stress, and the course of labor. However, there is limited high-quality evidence on whether keeping the labor room lighting dim has measurable benefits for mothers.

This study aims to evaluate the effects of dim light exposure during active labor on pain, anxiety, and labor progress. Pregnant women who are in active labor at term will be randomly assigned to one of two groups. One group will give birth in a room with dim lighting (50-80 lux), while the other group will receive standard room lighting as part of routine care.

Pain and anxiety levels will be measured at specific time points during labor using standard assessment scales. Information about labor duration, use of labor medications, mode of delivery, and newborn outcomes will also be collected.

The dim light intervention does not interfere with routine obstetric care and does not pose additional risk to the mother or baby. If needed for clinical reasons, room lighting can be increased immediately. The results of this study may help determine whether a simple change in the birth environment can improve maternal comfort and labor outcomes.

研究概览

详细说明

This study is a single-center, parallel-group randomized controlled trial designed to evaluate the effects of dim light exposure during active labor on maternal pain, anxiety, and labor progress. The trial is conducted in a university hospital labor ward and includes term pregnant women in active labor.

Eligible participants are women aged 18-45 years with a singleton, vertex-presenting pregnancy at ≥37 weeks of gestation who are in active labor. Eligible participants are individually randomized in a 1:1 ratio to either the dim-light intervention group or the standard-light control group using a predefined randomization sequence. Randomization is performed at the participant level after confirmation of eligibility and informed consent.

In the intervention group, labor room lighting is adjusted to a dim light environment with an illumination level maintained between 50 and 80 lux, using warm white or amber light sources. Light intensity is monitored at regular intervals using a lux meter. In the control group, routine labor room lighting conditions are maintained in accordance with standard clinical practice.

Pain intensity and anxiety levels are assessed at predefined time points during labor using validated measurement tools. Labor progress and obstetric outcomes, including use of labor augmentation, duration of labor stages, mode of delivery, and neonatal outcomes, are recorded from clinical charts.

The primary outcome is derived from changes in pain intensity over time during labor. Secondary outcomes include anxiety levels, labor characteristics, and maternal and neonatal clinical outcomes.

The dim light intervention is non-invasive and does not interfere with routine obstetric care. For clinical or safety reasons, room lighting can be increased immediately at any time at the discretion of the clinical team. All participants receive standard intrapartum care according to institutional protocols.

Study data are collected prospectively and stored in an anonymized format to ensure participant confidentiality. The study is conducted in accordance with ethical principles and has received approval from the relevant institutional ethics committee.

研究类型

介入性

注册 (实际的)

120

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Niğde Province
      • Niğde、Niğde Province、土耳其(türkiye)
        • Niğde Ömer Halisdemir University Hospital

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 45年 (成人)

接受健康志愿者

是的

有资格学习的性别

女性

描述

Inclusion Criteria:

Pregnant individuals aged 18-45 years

Singleton pregnancy

Vertex (cephalic) presentation

Gestational age ≥37 weeks

Active labor at enrollment (cervical dilation between 4 and 8 cm)

Ability to provide written informed consent

Exclusion Criteria:

Planned or ongoing epidural analgesia

Multiple pregnancy

Severe preeclampsia or other obstetric complications requiring immediate intervention

Known photosensitivity or light-related sensitivity disorders

History of psychiatric disorders that may interfere with anxiety assessment

Any condition deemed by the clinical team to require deviation from the study protocol

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Dim Light (50-80 Lux)

Labor room lighting will be maintained at 50-80 lux using warm white/amber light sources. Illumination will be monitored at regular intervals with a lux meter. Standard intrapartum care will be provided; lighting may be increased immediately if clinically needed.

Adjustment of labor room illumination to a target range of 50-80 lux during active labor, with monitoring using a lux meter; lighting can be increased at any time for clinical reasons.

有源比较器:Routine Lighting (Control)

Routine labor room lighting will be maintained according to standard clinical practice. Standard intrapartum care will be provided.

Standard labor room lighting conditions maintained according to routine clinical practice, without modification of illumination levels.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Pain intensity over time (VAS-AUC, 0-120 minutes)
大体时间:From baseline to 120 minutes during active labor

Pain intensity will be assessed using a 0-10 Visual Analog Scale (VAS) at baseline (0 minutes), 60 minutes, and 120 minutes after allocation. The area under the curve (AUC) for VAS from 0 to 120 minutes will be calculated as the primary outcome.

From baseline to 120 minutes during active labor

次要结果测量

结果测量
措施说明
大体时间
Anxiety level (six-item short-form state anxiety score)
大体时间:From baseline to 90 minutes during active labor

State anxiety was assessed at baseline (prior to intervention/exposure) and at 90 minutes during active labor using a six-item short form derived from the State scale of the State-Trait Anxiety Inventory (STAI). Each item was rated on a four-point scale, with positively worded items reverse-scored. Item scores were summed to yield a raw total score ranging from 6 to 24, with higher scores indicating greater state anxiety. The between-group difference in anxiety at 90 minutes was evaluated with adjustment for baseline anxiety score.

From baseline to 90 minutes during active labor
Oxytocin use (initiation rate and total dose)
大体时间:During labor until delivery

Proportion of participants who receive oxytocin augmentation and the total oxytocin dose administered during labor will be recorded from clinical charts.

During labor until delivery
Duration of active phase of labor
大体时间:From enrollment to full dilation

Time from enrollment during active labor to full cervical dilation will be recorded.

From enrollment to full dilation
Duration of second stage of labor
大体时间:From full dilation to delivery

Time from full cervical dilation to delivery will be recorded.

From full dilation to delivery
Mode of delivery
大体时间:At delivery

Vaginal delivery (spontaneous/assisted) and cesarean delivery will be recorded.

At delivery
Estimated blood loss
大体时间:At delivery / immediate postpartum

Estimated maternal blood loss at delivery will be recorded from clinical records.

At delivery / immediate postpartum
Neonatal outcomes (Apgar scores)
大体时间:1 and 5 minutes after birth

Neonatal well-being will be assessed using the Apgar scoring system at 1 and 5 minutes after birth. The Apgar score ranges from 0 to 10, based on five components (heart rate, respiratory effort, muscle tone, reflex irritability, and skin color). Higher Apgar scores indicate better neonatal condition (better outcome). Apgar scores at 1 and 5 minutes will be recorded and analyzed descriptively.

1 and 5 minutes after birth

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年1月6日

初级完成 (实际的)

2026年5月29日

研究完成 (实际的)

2026年5月30日

研究注册日期

首次提交

2025年12月16日

首先提交符合 QC 标准的

2025年12月16日

首次发布 (实际的)

2025年12月30日

研究记录更新

最后更新发布 (实际的)

2026年9月30日

上次提交的符合 QC 标准的更新

2026年9月26日

最后验证

2026年5月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

Individual participant data will not be shared due to the sensitive nature of intrapartum clinical data and the absence of participant consent for data sharing beyond the objectives of this study. De-identified aggregate results will be reported through publications.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅